Literature DB >> 26673280

Pancytopenia in Multiple Myeloma- An Enigma: Our Experience from Tertiary Care Hospital.

Hanaganahalli B Sridevi1, Sharada Rai2, Pooja K Suresh1, Meludurgamutt S Somesh3, Jessica Minal1.   

Abstract

INTRODUCTION: Multiple myeloma is a plasma cell neoplasm that is characterized by clonal proliferation of malignant plasma cell in the bone marrow along with M-protein in the serum and/or urine. Pancytopenia as a initial presentation of multiple myeloma is quite unusual. We are presenting a case series having pancytopenia as the presenting complaint.
MATERIALS AND METHODS: A retrospective study was conducted for a period of 30 months, wherein all the cases of multiple myeloma presenting with pancytopenia were included. The complete blood picture, peripheral smear examination, bone marrow aspirate & protein electrophoresis of all the cases were reviewed & analysed.
RESULTS: During the study period, 10 cases presented with pancytopenia with a mean age of 66.3 years (range: 59-72 years) at presentation with male: female ratio being 8:2. Fatigue and weakness was the most common symptom (100%) & average ESR was 104 mm/hour. High-resolution serum electrophoresis, showed a dense, sharp to wide M band in the gamma globulin region. Bone marrow plasma cell percentage was increased with an average of 63.1%. Bone marrow biopsy correlation was obtained in 100% cases.
CONCLUSION: Diagnosing multiple myeloma, presenting as pancytopenia requires a high degree of suspicion to avoid delay in initiation of treatment.

Entities:  

Keywords:  Clonal proliferation; Initial presentation; Plasma cell neoplasm

Year:  2015        PMID: 26673280      PMCID: PMC4668413          DOI: 10.7860/JCDR/2015/12788.6718

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  12 in total

1.  Thrombocytopenia and abnormal bleeding in multiple myeloma.

Authors:  T N JAMES; R W MONTO; J W REBUCK
Journal:  Ann Intern Med       Date:  1953-12       Impact factor: 25.391

2.  Guidelines on the diagnosis and management of multiple myeloma 2005.

Authors:  Alastair Smith; Finn Wisloff; Diana Samson
Journal:  Br J Haematol       Date:  2006-02       Impact factor: 6.998

3.  Histomorphology of multiple myeloma on bone marrow biopsy.

Authors:  Niti Singhal; Tejinder Singh; Zeba N Singh; D K Shome; Manorama Gaiha
Journal:  Indian J Pathol Microbiol       Date:  2004-07       Impact factor: 0.740

Review 4.  The differential diagnosis and bone marrow evaluation of new-onset pancytopenia.

Authors:  Elizabeth P Weinzierl; Daniel A Arber
Journal:  Am J Clin Pathol       Date:  2013-01       Impact factor: 2.493

Review 5.  Clinical significance of bone marrow biopsy and plasma cell morphology in MM and MGUS.

Authors:  R Bartl; B Frisch
Journal:  Pathol Biol (Paris)       Date:  1999-02

6.  Risk groups of myeloma patients by histologic pattern and proliferative activity.

Authors:  A Pich; L Chiusa; F Marmont; R Navone
Journal:  Am J Surg Pathol       Date:  1997-03       Impact factor: 6.394

Review 7.  Management of multiple myeloma: the changing landscape.

Authors:  Donna E Reece
Journal:  Blood Rev       Date:  2007-08-29       Impact factor: 8.250

8.  Prognostic significance of bone marrow histology in multiple myeloma.

Authors:  R Subramanian; D Basu; T K Dutta
Journal:  Indian J Cancer       Date:  2009 Jan-Mar       Impact factor: 1.224

9.  Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.

Authors: 
Journal:  Br J Haematol       Date:  2003-06       Impact factor: 6.998

10.  Ten-year survival and prognostic factors in multiple myeloma. Japan Myeloma Study Group.

Authors:  J Tsuchiya; H Murakami; T Kanoh; M Kosaka; T Sezaki; C Mikuni; M Kawato; T Takagi; A Togawa; T Isobe
Journal:  Br J Haematol       Date:  1994-08       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.